Literature DB >> 10561002

Prognostic factors in controlled ovarian hyperstimulation.

H Tinkanen1, M Bläuer, P Laippala, P Tuohimaa, E Kujansuu.   

Abstract

OBJECTIVE: To determine whether the number of retrieved oocytes and the required amount of gonadotropins per oocyte in IVF treatment can be predicted with use of the following independent predictive variables: age, parity, cause of infertility, body mass index, day 3-5 FSH, E2, inhibin B, ovarian volume, the number of follicles, and intraovarian and uterine artery vascular resistance measured by ultrasonography before ovarian hyperstimulation.
DESIGN: A retrospective analysis.
SETTING: University hospital infertility clinic. PATIENT(S): Seventy-four consecutive women attending the university hospital infertility clinic for IVF treatment. INTERVENTION(S): The investigated factors were measured on day 3-5 of the cycle, in which luteal phase suppression was begun before ovarian hyperstimulation preparatory to IVF. MAIN OUTCOME MEASURE(S): The amount of gonadotropins required per oocyte and the number of retrieved oocytes were correlated with the predictive factors in stepwise regression analysis. RESULT(S): The best predictive factors for the number of oocytes retrieved were FSH, inhibin B, and parity, explaining 25% of the ovarian response. Intraovarian vascular resistance, parity, FSH, and inhibin B best predicted the amount of gonadotropins needed, explaining 44% of the variation. CONCLUSION(S): FSH, inhibin B, and parity were the independent predictive factors for the number of retrieved oocytes. The same factors and intraovarian vascular resistance predicted the required amount of gonadotropins per oocyte. The main part of the ovarian response cannot be predicted using the factors investigated.

Entities:  

Mesh:

Year:  1999        PMID: 10561002     DOI: 10.1016/s0015-0282(99)00397-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Impact of body mass index on in vitro fertilization outcomes.

Authors:  John L Frattarelli; Catherine Lee Kodama
Journal:  J Assist Reprod Genet       Date:  2004-06       Impact factor: 3.412

2.  Body mass index, follicle-stimulating hormone and their predictive value in in vitro fertilization.

Authors:  Kathrin Ferlitsch; Michael O Sator; Doris M Gruber; Ernst Rücklinger; Christian J Gruber; Johannes C Huber
Journal:  J Assist Reprod Genet       Date:  2004-12       Impact factor: 3.412

3.  A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment.

Authors:  Seang Lin Tan; Timothy J Child; Anthony P Cheung; Margo R Fluker; Albert Yuzpe; Robert Casper; Peter Leung; Kenneth Cadesky; Victoria J Davis
Journal:  J Assist Reprod Genet       Date:  2005-02       Impact factor: 3.412

4.  The significance of antral follicle size prior to stimulation in predicting ovarian response in a multiple dose GnRH antagonist protocol.

Authors:  Qiaohong Lai; Cai Chen; Zhijun Zhang; Shu Zhang; Qilin Yu; Ping Yang; Jun Hu; Cong-Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

5.  Ovarian reserve assessment for infertility investigation.

Authors:  Bruno Ramalho de Carvalho; David Barreira Gomes Sobrinho; Andréa Duarte Damasceno Vieira; Manoela Porto Silva Resende; Antônio César Paes Barbosa; Adelino Amaral Silva; Hitomi Miura Nakagava
Journal:  ISRN Obstet Gynecol       Date:  2012-01-26

6.  Impact of GnRH ovarian stimulation protocols on intracytoplasmic sperm injection outcomes.

Authors:  Fátima Pinto; Cristiano Oliveira; Margarida F Cardoso; José Teixeira-da-Silva; Joaquina Silva; Mário Sousa; Alberto Barros
Journal:  Reprod Biol Endocrinol       Date:  2009-01-15       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.